GTranslate

Amsterdam 95-95-95 Targets (2020)

95%

94%

95%

Source: Provided by the City of Amsterdam

Amsterdam HIV Care Continuum (2020) PLHIV: 6,420

95%

90%

90%

86%

Source: Provided by the City of Amsterdam

The following counters and charts portray the current epidemiology of HIV. The charts have hovers and are changeable by clicking on them. They are also downloadable-see the download button.

6,420

Source: Provided by the City of Amsterdam

6,120

Source: Provided by the City of Amsterdam

5,802

Source: Provided by the City of Amsterdam

5,775

Source: Provided by the City of Amsterdam

5,496

Source: Provided by the City of Amsterdam

4,680

Source: Provided by the City of Amsterdam

4,550

Source: Provided by the City of Amsterdam

4,360

Source: Provided by the City of Amsterdam

4,340

Source: Provided by the City of Amsterdam

4,179

Source: Provided by the City of Amsterdam

120

Source: Provided by the City of Amsterdam

337

Source: Provided by the City of Amsterdam

366

Source: Provided by the City of Amsterdam

42

Source: Provided by the City of Amsterdam

0.74%

Source: Provided by the City of Amsterdam

13.9

Source: Provided by the City of Amsterdam

Amsterdam

Hover your mouse on bar for detailed data.

Methodology

The number of HIV-positive people by the end of 2018 was estimated by adding the total estimated number of people living with undiagnosed HIV to the observed number of diagnosed HIV-positive individuals living in Amsterdam, based on the first four digits of their most recent home address postal code. The number of undiagnosed people by the end of 2018 was estimated with the European Centre for Disease Prevention and Control (ECDC) HIV Modelling Tool, using annual data on new HIV diagnoses stratified by CD4 count at the time of diagnosis or a concurrent AIDS diagnosis. This method reconstructed the number of annual newly acquired HIV infections and the distribution of time between infection and diagnosis, and subsequently determined the proportion still undiagnosed. Retention in care was defined as at least one clinic visit, or a CD4 or RNA measurement in 2018. People were considered to be on antiretroviral treatment whenever they started antiretroviral treatment before the end of 2018. Viral suppression was defined as HIV RNA <200 copies/ml at the last RNA measurement in 2018, where people without a measurement in 2018 were considered unsuppressed.

Hover your mouse on bar for detailed data.

Hover on bar for detailed data.

Hover on bar for detailed data.

Methodology

The number of HIV-positive people by the end of 2019 was estimated by adding the total estimated number of people living with undiagnosed HIV to the observed number of diagnosed HIV-positive individuals living in Amsterdam, based on the first four digits of their most recent home address postal code. The number of undiagnosed people by the end of 2019 was estimated with the European Centre for Disease Prevention and Control (ECDC) HIV Modelling Tool, using annual data on new HIV diagnoses stratified by CD4 count at the time of diagnosis or a concurrent AIDS diagnosis. This method reconstructed the number of annual newly-acquired HIV infections and the distribution of time between infection and diagnosis, and subsequently determined the proportion still undiagnosed. Retention in care was defined as at least one clinic visit, or a CD4 or RNA measurement in 2019. People were considered to be on antiretroviral treatment whenever they started antiretroviral treatment before the end of 2019. Viral suppression was defined as HIV RNA <200 copies/ml at the last RNA measurement in 2019, where people without a measurement in 2019 were considered unsuppressed.

Hover on bar for detailed data.

Methodology

The number of HIV-positive people by the end of 2018 was estimated by adding the total estimated number of people living with undiagnosed HIV to the observed number of diagnosed HIV-positive individuals living in Amsterdam, based on the first four digits of their most recent home address postal code. The number of undiagnosed people by the end of 2018 was estimated with the European Centre for Disease Prevention and Control (ECDC) HIV Modelling Tool, using annual data on new HIV diagnoses stratified by CD4 count at the time of diagnosis or a concurrent AIDS diagnosis. This method reconstructed the number of annual newly acquired HIV infections and the distribution of time between infection and diagnosis, and subsequently determined the proportion still undiagnosed. Retention in care was defined as at least one clinic visit, or a CD4 or RNA measurement in 2018. People were considered to be on antiretroviral treatment whenever they started antiretroviral treatment before the end of 2018. Viral suppression was defined as HIV RNA <200 copies/ml at the last RNA measurement in 2018, where people without a measurement in 2018 were considered unsuppressed.

Hover on bar for detailed data.

Methodology

The number of HIV-positive people by the end of 2019 was estimated by adding the total estimated number of people living with undiagnosed HIV to the observed number of diagnosed HIV-positive individuals living in Amsterdam, based on the first four digits of their most recent home address postal code. The number of undiagnosed people by the end of 2019 was estimated with the European Centre for Disease Prevention and Control (ECDC) HIV Modelling Tool, using annual data on new HIV diagnoses stratified by CD4 count at the time of diagnosis or a concurrent AIDS diagnosis. This method reconstructed the number of annual newly-acquired HIV infections and the distribution of time between infection and diagnosis, and subsequently determined the proportion still undiagnosed. Retention in care was defined as at least one clinic visit, or a CD4 or RNA measurement in 2019. People were considered to be on antiretroviral treatment whenever they started antiretroviral treatment before the end of 2019. Viral suppression was defined as HIV RNA <200 copies/ml at the last RNA measurement in 2019, where people without a measurement in 2019 were considered unsuppressed.

Hover on bar for detailed data.

Hover on bar for detailed data.

Hover on bar for detailed data.

Hover on bar for detailed data.

Hover on bar for detailed data.

Hover on bar for detailed data.

Methodology

(AvS, 04/03/2021) calculated as the number in the first stage of the care continuum (=number with HIV by the end of the year) divided by the total population on 1 January of the following year

Kinshasa
Maputo
Yaoundé
Madrid
Amsterdam
Київ
São Paulo
Paris